NCT02462486

Brief Summary

This is a safety and efficacy study of abicipar pegol in participants with neovascular age-related macular degeneration.

Trial Health

98
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Strong global presence with extensive site network
Enrollment
949

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Jun 2015

Typical duration for phase_3

Geographic Reach
16 countries

187 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 2, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 4, 2015

Completed
21 days until next milestone

Study Start

First participant enrolled

June 25, 2015

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 12, 2018

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 6, 2019

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

July 30, 2020

Completed
Last Updated

July 30, 2020

Status Verified

July 1, 2020

Enrollment Period

2.8 years

First QC Date

June 2, 2015

Results QC Date

July 17, 2020

Last Update Submit

July 17, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage of Participants With Stable Vision at Week 52

    Stable vision was defined as vision loss of fewer than 15 letters in Best-corrected Visual Acuity (BCVA) from baseline. BCVA is measured using an eye chart and is reported as the number of letters read correctly using the ETDRS Scale (ranging from 0 to 100 letters) in the study eye. The lower the number of letters read correctly on the eye chart, the worse the vision (or visual acuity). An increase in the number of letters read correctly means that vision has improved. The percentage of participants with a BCVA loss of fewer than 15 letters are reported. Study eye was defined as the eye that meets the entry criteria. If both the eyes met all of the entry criteria, the eye with worse BCVA at baseline (Day 1) was selected. If BCVA values for both eyes were identical then participant had to select the non-dominant eye, or else right eye was selected as study eye.

    Baseline to Week 52

Secondary Outcomes (4)

  • Mean Change From Baseline in Best-corrected Visual Acuity (BCVA) in the Study Eye at Week 52

    Baseline to Week 52

  • Mean Change From Baseline in Central Retinal Thickness (CRT) in the Study Eye at Week 52

    Baseline to Week 52

  • Percentage of Participants With BCVA Gain of More Than 15 Letters From Baseline in the Study Eye at Week 52

    Baseline to Week 52

  • Mean Change From Baseline in the National Eye Institute Visual Functioning Questionnaire-25 (NEI-VFQ-25) Composite Score at Week 52

    Baseline to Week 52

Study Arms (3)

Abicipar Pegol 2 mg (2Q8)

EXPERIMENTAL

Abicipar pegol 2 mg was administered to the study eye by intravitreal injection on Day 1, Week 4, and Week 8, followed by injections every 8 weeks through Week 96. Scheduled visits occurred every 4 weeks. To maintain masking, sham was administered to the study eye at scheduled visits where abicipar was not administered.

Drug: Abicipar PegolOther: Sham Procedure

Abicipar Pegol 2 mg (2Q12)

EXPERIMENTAL

Abicipar pegol 2 mg was administered to the study eye by intravitreal injection on Day 1, Week 4, and Week 12, followed by injections every 12 weeks through Week 96. Scheduled visits occurred every 4 weeks. To maintain masking, sham was administered to the study eye at scheduled visits where abicipar was not administered.

Drug: Abicipar PegolOther: Sham Procedure

Ranibizumab (rQ4)

ACTIVE COMPARATOR

Ranibizumab (Lucentis®) was administered to the study eye by intravitreal injection every 4 weeks from Day 1 through Week 96.

Drug: Ranibizumab

Interventions

Abicipar pegol intravitreal injection.

Also known as: AGN-150998
Abicipar Pegol 2 mg (2Q12)Abicipar Pegol 2 mg (2Q8)

Ranibizumab intravitreal injection.

Also known as: Lucentis®
Ranibizumab (rQ4)

Sham injection.

Abicipar Pegol 2 mg (2Q12)Abicipar Pegol 2 mg (2Q8)

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of age-related macular degeneration in at least 1 eye
  • Best corrected visual acuity of 20/40 to 20/320 in the study eye
  • Best corrected visual acuity of 20/200 or better in the non-study eye

You may not qualify if:

  • History of vitrectomy, macular surgery, or glaucoma surgery in the study eye
  • Cataract or refractive surgery in the study eye within the last 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (187)

Eye Foundation Hospital

Birmingham, Alabama, 35233, United States

Location

Retinal Consultants of Arizona

Gilbert, Arizona, 85296, United States

Location

Barnet Dulaney Perkins Eye Center - Phoenix

Phoenix, Arizona, 85016-4701, United States

Location

Retina Centers, PC

Tucson, Arizona, 85704, United States

Location

Northwest Arkansas Retina Associates

Springdale, Arkansas, 72762, United States

Location

Win Retina

Arcadia, California, 91006, United States

Location

Retina Institute of California

Arcadia, California, 91007, United States

Location

Retinal Diagnostic Center

Campbell, California, 95008, United States

Location

Specialty Eye Care Medical Center, Inc.

Glendale, California, 91203, United States

Location

University of California at Irvine Gavin Herbert Eye Institute

Irvine, California, 92697-4375, United States

Location

Retina Associates of Orange County

Laguna Hills, California, 92653, United States

Location

South Coast Retina Center

Long Beach, California, 90807, United States

Location

East Bay Retina Consultants, Inc.

Oakland, California, 94609, United States

Location

San Diego Retina Associates

Oceanside, California, 92056, United States

Location

Southern California Desert Retina Consultants

Palm Desert, California, 92211, United States

Location

California Eye Specialist Medical Group

Pasadena, California, 91107, United States

Location

Retina Consultants, San Diego

Poway, California, 92064, United States

Location

Retina Consultants of Southern California

Redlands, California, 92374, United States

Location

Kaiser Permanente Riverside Medical Center

Riverside, California, 92505, United States

Location

UC Davis Medical Center, Department of Ophthalmology

Sacramento, California, 95817, United States

Location

Retinal Consultants Medical Group, Inc.

Sacramento, California, 95841, United States

Location

West Coast Retina Medical Group

San Francisco, California, 94109, United States

Location

Pacific Eye Associates

San Francisco, California, 94115, United States

Location

The Eye Associates

Bradenton, Florida, 34209, United States

Location

National Ophthalmic Research Institute

Fort Myers, Florida, 33912, United States

Location

Retina Macula Specialists of Miami

Miami, Florida, 33126, United States

Location

MedEye Associates

Miami, Florida, 33143, United States

Location

Fort Lauderdale Eye Institute

Plantation, Florida, 33324, United States

Location

Sarasota Retina Institute

Sarasota, Florida, 34239, United States

Location

East Florida Eye Institute

Stuart, Florida, 34994, United States

Location

Retina Associate of Florida, P.A.

Tampa, Florida, 33609, United States

Location

Retina Vitreous Associates of Florida

Tampa, Florida, 33617, United States

Location

Center for Retina and Macular Disease

Winter Haven, Florida, 33880, United States

Location

Southeast Retina Center

Augusta, Georgia, 30909, United States

Location

Rush University Medical Center

Chicago, Illinois, 60612, United States

Location

DuPage Medical Group

Downers Grove, Illinois, 60515, United States

Location

Kovach Eye Institute

Elmhurst, Illinois, 60126, United States

Location

University Retina and Macula Associates

Oak Forest, Illinois, 60452, United States

Location

Wheaton Eye Clinic, Clinical Research Center, LLC

Wheaton, Illinois, 60187, United States

Location

Sabates Eye Centers

Leawood, Kansas, 66211, United States

Location

Paducah Retinal Center

Paducah, Kentucky, 42001, United States

Location

The Retina Care Center

Baltimore, Maryland, 21209, United States

Location

Cumberland Valley Retina Consultants, P.C.

Hagerstown, Maryland, 21740, United States

Location

Vitreo-Retinal Associates, Pc

Worcester, Massachusetts, 01605, United States

Location

Retina Specialists of Michigan

Grand Rapids, Michigan, 49546, United States

Location

University of Mississippi Medical Center

Jackson, Mississippi, 39216, United States

Location

Retina Center of New Jersey, LLC

Bloomfield, New Jersey, 07003, United States

Location

Delaware Valley Retina Associates

Lawrenceville, New Jersey, 08648, United States

Location

Long Island Vitreoretinal Consultants

Hauppauge, New York, 11788, United States

Location

Maculacare - New York

New York, New York, 10021, United States

Location

Retina Vitreous Surgeons of Central NY, PC

Syracuse, New York, 13224, United States

Location

Western Carolina Retinal Associates, PA

Asheville, North Carolina, 28803, United States

Location

Charlotte Eye Ear Nose & Throat Associates, PA

Charlotte, North Carolina, 28210, United States

Location

Retina Associates of Cleveland, Inc

Beachwood, Ohio, 44122, United States

Location

Cincinnati Eye Institute

Cincinnati, Ohio, 45242-5664, United States

Location

Ohio State University

Columbus, Ohio, 43212, United States

Location

Midwest Retina, Inc.

Dublin, Ohio, 43016, United States

Location

Retina & Vitreous Center SO, PC

Ashland, Oregon, 97520, United States

Location

Oregon Health Sciences University

Portland, Oregon, 97239, United States

Location

Pennsylvania Retina Specialists, P.C.

Camp Hill, Pennsylvania, 17011, United States

Location

Black Hills Regional Eye Institute

Rapid City, South Dakota, 57701, United States

Location

Austin Retina Associates

Austin, Texas, 78705, United States

Location

Retina and Vitreous of Texas

Beaumont, Texas, 77707, United States

Location

The University of Texas Medical Branch

Galveston, Texas, 77550, United States

Location

Premiere Retina Specialists

Midland, Texas, 79706, United States

Location

Retina Associates of South Texas, PA

San Antonio, Texas, 78240, United States

Location

Strategic Clinical Research Group, LLC

Willow Park, Texas, 76087, United States

Location

University of Utah, John Moran Eye Center

Salt Lake City, Utah, 84132, United States

Location

Virginia Eye Consultants

Norfolk, Virginia, 23502, United States

Location

Wagner Macula and Retina Center

Virginia Beach, Virginia, 23454, United States

Location

Vitreoretinal Associates of Washington

Bellevue, Washington, 98004, United States

Location

Spokane Eye Clinical Research

Spokane, Washington, 99204, United States

Location

West Virginia University Eye Institute

Morgantown, West Virginia, 26506, United States

Location

Save Sight Institute, University of Sydney Eye Hospital

Sydney, New South Wales, 2000, Australia

Location

Sydney Retina Clinic and Day Surgery

Sydney, New South Wales, 2000, Australia

Location

Sydney West Retina

Westmead, New South Wales, 2145, Australia

Location

Centre for Eye Research Australia

East Melbourne, Victoria, 3002, Australia

Location

Specialist Eye Group

Glen Waverley, Victoria, 3150, Australia

Location

Lions Eye Institute

Nedlands, Western Australia, 6009, Australia

Location

Centro Brasileiro de Cirurgia de Olhos - CBCO

Goiânia, Goiás, 74210-010, Brazil

Location

Instistuto da Visao - Hospital de Olhos Ltda

Belo Horizonte, Minas Gerais, 30330-000, Brazil

Location

Hospital Oftalmologico de Sorocaba

Sorocaba, São Paulo, 18031-060, Brazil

Location

Clinica de Olhos Dr. Suel Abujamra

São Paulo, 01525-001, Brazil

Location

Instituto Da Visao UNIFESP EPM (Universidade Federal de Sao Paulo - Escola Paulista de Medicina)

São Paulo, 04023-062, Brazil

Location

Calgary Retina Consultants

Calgary, Alberta, T2H 0C8, Canada

Location

St Joseph's Health Care London - Ivey Eye Institute

London, Ontario, N6A 4V2, Canada

Location

Canadian Centre for Advanced Eye Therapeutics Inc

Mississauga, Ontario, L4W 1W9, Canada

Location

University of Ottawa Eye Institute

Ottawa, Ontario, K1H 8L6, Canada

Location

Toronto Retina Institute

Toronto, Ontario, M3C0G9, Canada

Location

Rigshospitalet-Glostrup

Glostrup Municipality, Capital Region, 2600, Denmark

Location

Odense University Hospital

Odense, Region Syddanmark, C 5000, Denmark

Location

Magyar Honvedseg Egeszegugyi Kozpont

Budapest, 1068, Hungary

Location

Semmelweis University

Budapest, 1085, Hungary

Location

Bajcsy-Zsilinszky Hospital

Budapest, 1106, Hungary

Location

Szent Imre Teaching Hospital

Budapest, 1115, Hungary

Location

Budapest Retina Associates Kft.

Budapest, 1133, Hungary

Location

University of Debrecen, Medical Center

Debrecen, 4032, Hungary

Location

Ganglion Medical Centre

Pécs, 7621, Hungary

Location

University of Szeged

Szeged, 6720, Hungary

Location

Markusovszki Teaching Hospital

Szombathely, 9700, Hungary

Location

Ospedale Clinicizzato

Chieti, Abruzzo, 66100, Italy

Location

Clinica Oculistica, Ospedale Santa Maria della Misericordia

Udine, Friuli Venezia Giulia, 33100, Italy

Location

Eye Clinic - Fondazione IRCCS

Milan, Lombardy, 20122, Italy

Location

Clinica Oculistica- Dipartimento di Scienze Cliniche Universita di Milano

Milan, Lombardy, 20157, Italy

Location

Ospedale Molinette

Turin, Piedmont, 10126, Italy

Location

Azienda Ospedaliero-Universitaria Careggi - SOD Oculistica, Dipartimento di Chirurgia e Medicina Traslazionale

Florence, Tuscany, 50134, Italy

Location

Azienda Universitaria Ospedaliera Pisana, Ospedale "Nuovo S.Chiara" Cisanello

Pisa, Tuscany, 56124, Italy

Location

IRCCS - Istuto di Recovero e Cura a Carattere Scientifico

Verona, Vento, 37024, Italy

Location

A.O.U. Policlinico Sant Orsola Malpighi Pad1, 4Piano, Studio Medici via Pelagio Palagi 9

Bologna, 40138, Italy

Location

Clinica Oculistica DINOGMI Universita di Genova

Genova, 16132, Italy

Location

IRCCS Ospedale San Raffaele

Milan, 20132, Italy

Location

Policlinico Agostino Gemelli

Roma, 00168, Italy

Location

Fondazione G.B. Bietti-IRCCS

Roma, 00198, Italy

Location

Aichi Medical University Hospital

Nagakute, Aichi-ken, 480-1195, Japan

Location

Japan Community Health Care Organization Chukyo Hospital

Nagoya, Aichi-ken, 457-8510, Japan

Location

Nagoya University Hospital

Nagoya, Aichi-ken, 466-8560, Japan

Location

Kameda Clinic

Kamogawa, Chiba, 296-0041, Japan

Location

Toho University Sakura Medical Center

Sakura, Chiba, 285-8741, Japan

Location

Juntendo University Urayasu Hospital

Urayasu, Chiba, 279-0021, Japan

Location

Ogaki Tokushukai Hospital

Ōgaki, Gifu, 503-0015, Japan

Location

Kimura Eye And Internal Medicine Hospital

Kure, Hiroshima, 737-0029, Japan

Location

Sapporo City General Hospital

Sapporo, Hokkaido, 060-8604, Japan

Location

Hyogo Prefectural Amagasaki Hospital General Medical Center

Amagasaki, Hyōgo, 660-8550, Japan

Location

Tokyo Medical University Ibaraki Medical Center

Inashiki, Ibaraki, 300-0395, Japan

Location

Mito Kyodo General Hospital

Mito, Ibaraki, 310-0015, Japan

Location

Otakeganka Tsukimino Clinic

Yamato, Kanagawa, 242-0001, Japan

Location

Kikuna Yuda Eye Clinic

Kanagawa, Kanto, 222-0011, Japan

Location

Mie University Hospital

Tsu, Mie-ken, 514-8507, Japan

Location

Iida Municipal Hospital

Iida, Nagano, 395-8502, Japan

Location

Shiga University of Medical Science Hospital

Ōtsu, Shiga, 520-2192, Japan

Location

Seirei Hamamatsu General Hospital

Hamamatsu, Shizuoka, 430-8558, Japan

Location

Nihon University Hospital

Chiyoda City, Tokyo, 101-8309, Japan

Location

Chofu Eye Clinic

Chōfu, Tokyo, 182-0024, Japan

Location

Tokyo Medical University Hachioji Medical Center

Hachiōji, Tokyo, 193-0998, Japan

Location

Takeuchi Eye Clinic

Taitō City, Tokyo, 111-0051, Japan

Location

Kyushu University Hospital

Fukuoka, 812-8582, Japan

Location

Fukushima Medical University Hospital

Fukushima, 960-1295, Japan

Location

Kokura Kinen Hospital

Kitakyushu, 802-8555, Japan

Location

Ideta Eye Hospital

Kumamoto, 860-0027, Japan

Location

The Japanese Red Cross Nagasaki Genbaku Hospital

Nagasaki, 852-0851, Japan

Location

Nara Medical University Hospital

Nara, 634-8522, Japan

Location

Medical Corporation Jinshikai Nishi Eye Hospital

Osaka, 537-0025, Japan

Location

Musashi Dream Clinic

Osaka, 543-0027, Japan

Location

Tane Memorial Eye Hospital

Osaka, 550-0024, Japan

Location

Tokyo Women's Medical University Hospital

Tokyo, 162-8666, Japan

Location

Elisabeth Hospital

Tilburg, North Brabant, 5022 GC, Netherlands

Location

Academic Medical Center

Amsterdam, North Holland, 1105 AZ, Netherlands

Location

Oogziekenhuis Rotterdam

Rotterdam, North Holland, 3011 BH, Netherlands

Location

Leiden University Medical Center

Leiden, South Holland, 2333 ZA, Netherlands

Location

Macula D&T Eye Center

San Isidro, Lima region, 27, Peru

Location

Optimum Profesorskie Centrum Okulistyki

Gdansk, 80-809, Poland

Location

Klinika Okulistyczna Jasne Blonia

Lodz, 91-134, Poland

Location

Centrum Diagnostyki i Mikrochirurgii

Olsztyn, 10-424, Poland

Location

Retina Eye Hospital

Warsaw, 01-364, Poland

Location

Uniwersytecki Szpital Kliniczny

Wroclaw, 50-556, Poland

Location

Scientific Research Institute of Ocular Diseases of RAMS

Moscow, 119021, Russia

Location

S. Fyodorov Eye Microsurgery Federal State Institution

Moscow, 127486, Russia

Location

Pasteur Medical Centre

Bloemfontein, 9301, South Africa

Location

Dr Actons Privat Practice

Cape Town, 7530, South Africa

Location

Pretoria Eye Institute, Private Practice

Pretoria, 0007, South Africa

Location

Department of Ophthalmology Kaohsiung Veterans General Hospital

Kaohsiung City, 813, Taiwan

Location

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, 833, Taiwan

Location

Department of Ophthalmology National Taiwan University Hospital

Taipei, 100, Taiwan

Location

Shin Kong Wu Ho-Su Memorial Hospital

Taipei, 111, Taiwan

Location

Chang Gung Medical Foundation, Linkou Branch

Taoyuan District, 333, Taiwan

Location

Ankara Uni Med Fac

Ankara, 06590, Turkey (Türkiye)

Location

Dokuz Eylul Uni Med Fac

Izmir, 35340, Turkey (Türkiye)

Location

Frimley Park Hospital

Frimley, Camberley, GU17 7UJ, United Kingdom

Location

Royal Derby Hospital

Derby, Derbyshire, DE22 3NE, United Kingdom

Location

ESNEFT Essex County Hospital

Colchester, Essex, CO4 5JR, United Kingdom

Location

University Hospital Southampton

Southampton, Hampshire, SO16 6YD, United Kingdom

Location

Oxford Eye Hospital, John Radcliffe Hospital

Oxford, Headington, OX3 9DU, United Kingdom

Location

Royal Liverpool University Hospital

Liverpool, North West England, L7 8XP, United Kingdom

Location

Royal Surrey Hospital

Guildford, South East, S10 2TB, United Kingdom

Location

Heart of England NHS Foundation Trust, Good Hope Hospital

Sutton Coldfield, Staffordshire, B75 7RR, United Kingdom

Location

University Hospital of Wales

Cardiff, Wales, CF4 4XW, United Kingdom

Location

Bradford Royal Infirmary (BRI)

Bradford, West Yorkshire, BD18 4JN, United Kingdom

Location

Sheffield Teaching Hospitals

Sheffield, Yorkshire, S10 2TB, United Kingdom

Location

Barnet Hospital

Barnet, EN5 3DJ, United Kingdom

Location

Bristol Eye Hospital

Bristol, BS1 2LX, United Kingdom

Location

University Hospital Aintree

Liverpool, L9 7AL, United Kingdom

Location

Moorfields Eye Hospital

London, EC1V 2PD, United Kingdom

Location

Barnet Royal Free Hospital

London, EN53DJ, United Kingdom

Location

King's College Hospital

London, SE5 9RJ, United Kingdom

Location

Royal Victoria Infirmary

Newcastle, NE1 4LP, United Kingdom

Location

Hospital of St. Cross

Rugby, CV22 5PX, United Kingdom

Location

City Hospitals Sunderland NHS

Sunderland, SR2 9HP, United Kingdom

Location

MeSH Terms

Conditions

Macular Degeneration

Interventions

abicipar pegolRanibizumab

Condition Hierarchy (Ancestors)

Retinal DegenerationRetinal DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Antibodies, Monoclonal, HumanizedAntibodies, MonoclonalAntibodiesImmunoglobulinsImmunoproteinsBlood ProteinsProteinsAmino Acids, Peptides, and ProteinsSerum GlobulinsGlobulins

Results Point of Contact

Title
Clinical Trials Registry Team
Organization
Allergan, Inc

Study Officials

  • Joanne Li

    Allergan

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 2, 2015

First Posted

June 4, 2015

Study Start

June 25, 2015

Primary Completion

April 12, 2018

Study Completion

June 6, 2019

Last Updated

July 30, 2020

Results First Posted

July 30, 2020

Record last verified: 2020-07

Locations